Free Trial

Iradimed (IRMD) Insider Trading & Ownership

Iradimed logo
$53.62 +0.62 (+1.17%)
(As of 02:42 PM ET)

Iradimed (NASDAQ:IRMD) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
37.10%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
2
Amount Of
Insider Selling
(Last 12 Months)
$585,850.00
Get IRMD Insider Trade Alerts

Want to know when executives and insiders are buying or selling Iradimed stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

IRMD Insider Buying and Selling by Quarter

Iradimed Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/2/2024John GlennCFOSell2,500$54.18$135,450.00  
12/26/2023Roger E SusiCEOSell5,000$46.00$230,000.00  
12/18/2023Roger E SusiCEOSell5,000$44.08$220,400.00  
(Data available from 1/1/2013 forward)

IRMD Insider Trading Activity - Frequently Asked Questions

The list of insiders at Iradimed includes Anthony Vuoto, Christopher K Scott, James B Hawkins, John Glenn, Monty K Allen, and Roger E Susi. Learn more on insiders at IRMD.

37.10% of Iradimed stock is owned by insiders. Learn more on IRMD's insider holdings.

The following insiders have sold IRMD shares in the last 24 months: Anthony Vuoto ($121,567.13), James B Hawkins ($232,853.46), John Glenn ($135,450.00), Monty K Allen ($128,239.58), and Roger E Susi ($12,177,121.23).

Insiders have sold a total of 297,121 Iradimed shares in the last 24 months for a total of $12,795,231.40 sold.

Iradimed Key Executives

  • Mr. Roger E. Susi (Age 71)
    Founder, Chairman, CEO & President
    Compensation: $642.57k
  • Mr. John F. Glenn (Age 62)
    CFO & Corporate Secretary
    Compensation: $541.71k
    1 recent trades
  • Mr. Randy Waddell
    Vice President of Worldwide Sales & Marketing
  • Mr. Chris Williamson
    Executive Vice President of Continuous Improvement & Information Technology
  • Mr. Matt Garner
    Controller
  • Mr. Steve Kachelmeyer
    Vice President of Regulatory Affairs & Quality Assurance
  • Mr. Lynn Neuhardt
    Vice President of Research & Development


This page (NASDAQ:IRMD) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners